Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 137

1.

Predominance of Uganda genotype of Mycobacterium tuberculosis isolated from Ugandan patients with tuberculous lymphadenitis.

Wamala D, Okee M, Kigozi E, Couvin D, Rastogi N, Joloba M, Kallenius G.

BMC Res Notes. 2015 Sep 1;8(1):398. doi: 10.1186/s13104-015-1362-y.

2.

Incubation time of Mycobacterium tuberculosis complex sputum cultures in BACTEC MGIT 960: 4weeks of negative culture is enough for physicians to consider alternative diagnoses.

Ogwang S, Mubiri P, Bark CM, Joloba ML, Boom WH, Johnson JL.

Diagn Microbiol Infect Dis. 2015 Jul 9. pii: S0732-8893(15)00228-X. doi: 10.1016/j.diagmicrobio.2015.07.002. [Epub ahead of print]

PMID:
26239846
3.

Predictors for MTB Culture-Positivity among HIV-Infected Smear-Negative Presumptive Tuberculosis Patients in Uganda: Application of New Tuberculosis Diagnostic Technology.

Nakiyingi L, Nonyane BA, Ssengooba W, Kirenga BJ, Nakanjako D, Lubega G, Byakika-Kibwika P, Joloba ML, Ellner JJ, Dorman SE, Mayanja-Kizza H, Manabe YC.

PLoS One. 2015 Jul 29;10(7):e0133756. doi: 10.1371/journal.pone.0133756. eCollection 2015.

4.

High Genotypic Discordance of Concurrent Mycobacterium tuberculosis Isolates from Sputum and Blood of HIV-Infected Individuals.

Ssengooba W, Cobelens FG, Nakiyingi L, Mboowa G, Armstrong DT, Manabe YC, Joloba ML, de Jong BC.

PLoS One. 2015 Jul 15;10(7):e0132581. doi: 10.1371/journal.pone.0132581. eCollection 2015.

5.

Essential Oils from Ugandan Aromatic Medicinal Plants: Chemical Composition and Growth Inhibitory Effects on Oral Pathogens.

Ocheng F, Bwanga F, Joloba M, Softrata A, Azeem M, PĆ¼tsep K, Borg-Karlson AK, Obua C, Gustafsson A.

Evid Based Complement Alternat Med. 2015;2015:230832. doi: 10.1155/2015/230832. Epub 2015 Jun 10.

6.

Capacity for science in sub-Saharan Africa.

Elliott A, Nerima B, Bagaya B, Kambugu A, Joloba M, Cose S, Pantaleo G, Yazdanbakhsh M, Mabey D, Dunne D, Moffett A, Rwakishaya EK, Kaleebu P, Mbidde EK.

Lancet. 2015 Jun 20;385(9986):2435-7. doi: 10.1016/S0140-6736(15)61111-4. No abstract available.

PMID:
26122054
7.

Predictors and outcomes of mycobacteremia among HIV-infected smear- negative presumptive tuberculosis patients in Uganda.

Nakiyingi L, Ssengooba W, Nakanjako D, Armstrong D, Holshouser M, Kirenga BJ, Shah M, Mayanja-Kizza H, Joloba ML, Ellner JJ, Dorman SE, Manabe YC.

BMC Infect Dis. 2015 Feb 15;15:62. doi: 10.1186/s12879-015-0812-4.

8.

Use of real time polymerase chain reaction for detection of M. tuberculosis, M. avium and M. kansasii from clinical specimens.

Bainomugisa A, Wampande E, Muchwa C, Akol J, Mubiri P, Ssenyungule H, Matovu E, Ogwang S, Joloba M.

BMC Infect Dis. 2015 Apr 14;15:181. doi: 10.1186/s12879-015-0921-0.

9.

Variation and risk factors of drug resistant tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis.

Lukoye D, Ssengooba W, Musisi K, Kasule GW, Cobelens FG, Joloba M, Gomez GB.

BMC Public Health. 2015 Mar 25;15:291. doi: 10.1186/s12889-015-1614-8.

10.

Pertussis prevalence and its determinants among children with persistent cough in urban Uganda.

Kayina V, Kyobe S, Katabazi FA, Kigozi E, Okee M, Odongkara B, Babikako HM, Whalen CC, Joloba ML, Musoke PM, Mupere E.

PLoS One. 2015 Apr 15;10(4):e0123240. doi: 10.1371/journal.pone.0123240. eCollection 2015.

11.
12.

Optimizing tuberculosis case detection through a novel diagnostic device placement model: the case of Uganda.

Pho MT, Deo S, Palamountain KM, Joloba ML, Bajunirwe F, Katamba A.

PLoS One. 2015 Apr 1;10(4):e0122574. doi: 10.1371/journal.pone.0122574. eCollection 2015.

13.

Improving the sensitivity of the Xpert MTB/RIF assay on sputum pellets by decreasing the amount of added sample reagent: a laboratory and clinical evaluation.

Dharan NJ, Amisano D, Mboowa G, Ssengooba W, Blakemore R, Kubiak RW, Armstrong DT, Jones M, Manabe YC, Joloba ML, Ellner JJ, Dorman SE, Alland D.

J Clin Microbiol. 2015 Apr;53(4):1258-63. doi: 10.1128/JCM.03619-14. Epub 2015 Feb 4.

PMID:
25653410
14.

Comparison of MGIT and Myco/F lytic liquid-based blood culture systems for recovery of Mycobacterium tuberculosis from pleural fluid.

Harausz E, Lusiba JK, Nsereko M, Johnson JL, Toossi Z, Ogwang S, Boom WH, Joloba ML; Tuberculosis Research Unit (TBRU).

J Clin Microbiol. 2015 Apr;53(4):1391-4. doi: 10.1128/JCM.02742-14. Epub 2015 Feb 4.

PMID:
25653400
15.

Tuberculosis risk factors among tuberculosis patients in Kampala, Uganda: implications for tuberculosis control.

Kirenga BJ, Ssengooba W, Muwonge C, Nakiyingi L, Kyaligonza S, Kasozi S, Mugabe F, Boeree M, Joloba M, Okwera A.

BMC Public Health. 2015 Jan 21;15:13. doi: 10.1186/s12889-015-1376-3.

16.

Feasibility of establishing a biosafety level 3 tuberculosis culture laboratory of acceptable quality standards in a resource-limited setting: an experience from Uganda.

Ssengooba W, Gelderbloem SJ, Mboowa G, Wajja A, Namaganda C, Musoke P, Mayanja-Kizza H, Joloba ML.

Health Res Policy Syst. 2015 Jan 15;13:4. doi: 10.1186/1478-4505-13-4.

17.

TB-HAART trial--authors' reply.

Mfinanga SG, Kirenga BJ, Chanda DM, Connolly C, Mwaba P, Joloba M, Zumla A; TB-HAART Study Group.

Lancet Infect Dis. 2015 Jan;15(1):15-6. doi: 10.1016/S1473-3099(14)71051-5. No abstract available.

PMID:
25541163
18.

The Mycobacterium tuberculosis Uganda II family and resistance to first-line anti-tuberculosis drugs in Uganda.

Ezati N, Lukoye D, Wampande EM, Musisi K, Kasule GW, Cobelens FG, Kateete DP, Joloba ML.

BMC Infect Dis. 2014 Dec 19;14:703. doi: 10.1186/s12879-014-0703-0.

19.

Polymorphisms in TICAM2 and IL1B are associated with TB.

Hall NB, Igo RP Jr, Malone LL, Truitt B, Schnell A, Tao L, Okware B, Nsereko M, Chervenak K, Lancioni C, Hawn TR, Mayanja-Kizza H, Joloba ML, Boom WH, Stein CM; Tuberculosis Research Unit.

Genes Immun. 2015 Mar;16(2):127-33. doi: 10.1038/gene.2014.77. Epub 2014 Dec 18.

20.

Cellular immune activation in cerebrospinal fluid from ugandans with cryptococcal meningitis and immune reconstitution inflammatory syndrome.

Meya DB, Okurut S, Zziwa G, Rolfes MA, Kelsey M, Cose S, Joloba M, Naluyima P, Palmer BE, Kambugu A, Mayanja-Kizza H, Bohjanen PR, Eller MA, Wahl SM, Boulware DR, Manabe YC, Janoff EN.

J Infect Dis. 2015 May 15;211(10):1597-606. doi: 10.1093/infdis/jiu664. Epub 2014 Dec 9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk